120 related articles for article (PubMed ID: 8962703)
1. Rat pancreas after long-term treatment with the somatostatin analogue octreotide.
von Schönfeld J; Meisse F; Müller MK
Exp Physiol; 1995 Nov; 80(6):1031-8. PubMed ID: 8962703
[TBL] [Abstract][Full Text] [Related]
2. Endocrine and exocrine pancreatic function after camostate-induced growth of the organ.
von Schönfeld J; Rünzi M; Goebell H; Müller MK
Experientia; 1995 Jun; 51(6):556-60. PubMed ID: 7607295
[TBL] [Abstract][Full Text] [Related]
3. Age-dependent influence of octreotide on stimulated pancreatic growth in the postnatal period of rats.
Kisfalvi K; Friess H; Büchler MW; Tulassay Z; Varga G; Papp M
Eur J Gastroenterol Hepatol; 1996 Jan; 8(1):69-74. PubMed ID: 8900912
[TBL] [Abstract][Full Text] [Related]
4. Influence of CCK antagonist L-364,718, pancreastatin (33-49) and a somatostatin analogue on camostate-induced rat pancreatic hypertrophy.
Schmidt WE; Stöckmann F; Choudhury AR; Wilms HM; Siegel EG; Nustede R; Fölsch UR; Creutzfeldt W
Digestion; 1989; 44(2):105-16. PubMed ID: 2612749
[TBL] [Abstract][Full Text] [Related]
5. Role of cholecystokinin in cholestyramine-induced changes of the exocrine pancreas.
Koop I; Lindenthal M; Schade M; Trautmann M; Adler G; Arnold R
Pancreas; 1991 Sep; 6(5):564-70. PubMed ID: 1946314
[TBL] [Abstract][Full Text] [Related]
6. Effect of a new CCK-A receptor antagonist, dexloxiglumide, on the exocrine pancreas in the rat.
Varga G; Kisfalvi K; D'Amato M; Scarpignato C
J Physiol Paris; 1997; 91(3-5):257-64. PubMed ID: 9403804
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.
Niederau C; Liddle RA; Williams JA; Grendell JH
Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964
[TBL] [Abstract][Full Text] [Related]
8. Effects of trypsin inhibitor (camostate) on pancreas and CCK release in young and old female rats.
Miyasaka K; Nakamura R; Kitani K
J Gerontol; 1989 Jul; 44(4):M136-40. PubMed ID: 2738309
[TBL] [Abstract][Full Text] [Related]
9. Chronic effects of camostate on growth and endocrine function of the pancreas in streptozotocin-induced diabetic rats.
Kogire M; Inoue K; Gu Y; Uchida K; Imamura M
Proc Soc Exp Biol Med; 1993 Nov; 204(2):201-5. PubMed ID: 8415777
[TBL] [Abstract][Full Text] [Related]
10. Chronic oral administration of synthetic trypsin inhibitor camostate reduces amylase release from isolated rat pancreatic acini.
Otsuki M; Fujii M; Nakamura T; Tani S; Okabayashi Y
Int J Pancreatol; 1995 Oct; 18(2):135-43. PubMed ID: 8530829
[TBL] [Abstract][Full Text] [Related]
11. Effect of prolonged administration of long-acting somatostatin on caerulein, CCK-8 and GRP induced pancreatic growth in the rat.
Hajri A; Aprahamian M; Damgé C
Regul Pept; 1991 Feb; 32(2):227-37. PubMed ID: 1709749
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effect of lorglumide on pancreatic growth stimulated by camostate in rat and hamster.
Douglas BR; Woutersen RA; Jansen JB; Rovati LC; Lamers CB
Life Sci; 1990; 46(4):281-6. PubMed ID: 2304371
[TBL] [Abstract][Full Text] [Related]
13. Effect of a specific serine protease inhibitor on the rat pancreas: systemic administration of camostate and exocrine pancreatic secretion.
Göke B; Stöckmann F; Müller R; Lankisch PG; Creutzfeldt W
Digestion; 1984; 30(3):171-8. PubMed ID: 6209186
[TBL] [Abstract][Full Text] [Related]
14. Endogenous somatostatin possibly controls pancreatic growth: further evidence for feedback regulation.
Rünzi M; Müller MK; Goebell H
Regul Pept; 1993 Aug; 47(1):65-72. PubMed ID: 8105514
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of proteinase inhibitor camostat on exocrine pancreas in fed and fasted rats.
Otsuki M; Tani S; Fujii M; Nakamura T; Okabayashi Y; Koide M
Am J Physiol; 1993 Oct; 265(4 Pt 2):R896-901. PubMed ID: 7694489
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human exocrine pancreatic secretion by the long-acting somatostatin analogue octreotide (SMS 201-995).
Kemmer TP; Malfertheiner P; Büchler M; Friess H; Meschenmoser L; Ditschuneit H
Aliment Pharmacol Ther; 1992 Feb; 6(1):41-50. PubMed ID: 1371938
[TBL] [Abstract][Full Text] [Related]
17. Effects of L-364,718, a new cholecystokinin receptor antagonist, on camostate-induced growth of the rat pancreas.
Wisner JR; McLaughlin RE; Rich KA; Ozawa S; Renner IG
Gastroenterology; 1988 Jan; 94(1):109-13. PubMed ID: 3335282
[TBL] [Abstract][Full Text] [Related]
18. The effect of trypsin inhibitor on the pancreas and small intestine of mice.
Ge YC; Morgan RG
Br J Nutr; 1993 Jul; 70(1):333-45. PubMed ID: 8399113
[TBL] [Abstract][Full Text] [Related]
19. Effect of synthetic protease inhibitor camostate on pancreatic exocrine function in rats.
Otsuki M; Ohki A; Okabayashi Y; Suehiro I; Baba S
Pancreas; 1987; 2(2):164-9. PubMed ID: 3628222
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of atropine and a cholecystokinin receptor antagonist on pancreatic secretion.
Adler G; Reinshagen M; Koop I; Göke B; Schafmayer A; Rovati LC; Arnold R
Gastroenterology; 1989 Apr; 96(4):1158-64. PubMed ID: 2647576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]